|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,
In June 2022, the Paul-Ehrlich-Institut organised a two-day virtual expert workshop on behalf of the COMBINE project. The workshop aimed to address the challenges in developing monoclonal antibodies (mAbs) against antimicrobial resistance (AMR) pathogens, with a specific focus on ESCAPE pathogens (E. faecium, S. aureus, C. difficile, A. baumannii, P. aeruginosa, and Enterobacteriaceae). The workshop […] |
3 events,
-
JPIAMR in partnership with the Medical Research Council (MRC UKRI) are hosting a workshop on antibiotic resistance, specifically looking for input from Early to Mid-Career Researchers. Antibiotic resistance is prevalent in bacterial infections across the world, threatening many of the fundamentals of modern medicine. A huge amount of work and funding has been focussed on […]
-
A 30-minute public webinar will be held on June 9, 2022 at 09:00 AM EDT with representatives from CARB-X, BARDA, Wellcome and NIAID to discuss the global health issues of AMR, and how CARB-X and its partners are working together to address them. The webinar celebrates a recent announcement in which BARDA and Wellcome have committed up to an additional […] |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
Vaccination programs are known to be effective to both promote the prudent use of antibiotics and to prevent the spread of AMR. JPIAMR, in partnership with the Medical Research Council and BactiVac Network, are holding a live webinar to identify opportunities and priorities for vaccine research from an immunological perspective to a wider translational context, in the field […] |
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
The prosperity of the modern world is threatened by the emergence of drug resistant pathogens, pesticide-resistant insects and herbicide-resistant weeds. Novel investigational cancer drugs increase life expectancy, but fail when resistance develops. The same principles of evolution drive the development of resistance in all of these contexts, yet each field attacks the problem of resistance […] |
|
0 events,
|
0 events,
|